Key facts
- This page summarizes Azita Saleki-Gerhardt's Form 4 filing for AbbVie Inc. (ABBV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2026, 18:10.
Azita Saleki-Gerhardt - 27 Feb 2026 Form 4 Insider Report for AbbVie Inc. (ABBV)
- Reporting relationship
- EVP, CHIEF OPERATIONS OFFICER
- Issuer ticker
- ABBV
- Reported as of
- 27 Feb 2026
- Net transaction value
- -$3,784,993
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2026, 18:10:10 UTC
- Prior SEC filing
- 20 Feb 2026
- Next SEC filing
- 08 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ T.O. Odutayo, Attorney-in-Fact for Azita Saleki-Gerhardt
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Azita Saleki-Gerhardt filed Form 4 for AbbVie Inc. (ABBV) on 03 Mar 2026.
Change
- Previous filing in this sequence was filed on 20 Feb 2026.
- Current net transaction value: -$3,784,993.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001563545
Primary reporting owner
SALEKI-GERHARDT AZITA
- Relationship
- EVP, CHIEF OPERATIONS OFFICER
- Address
- 1 N. WAUKEGAN ROAD, NORTH CHICAGO
- Signature
- /s/ T.O. Odutayo, Attorney-in-Fact for Azita Saleki-Gerhardt
- Signature date
- 03 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ABBV
transaction
Common Stock, $0.01 par value
Tax liability
- Transaction value
- $3,784,993
- Shares
- -16,309
- Change %
- -7.6%
- Price
- $232.08
- Shares after
- 197,794
- Date
- 27 Feb 2026
- Ownership
- Direct
ABBV
holding
Common Stock, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,706
- Date
- 27 Feb 2026
- Ownership
- Profit sharing trust
- Footnotes
- F1
ABBV
holding
Common Stock, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,873
- Date
- 27 Feb 2026
- Ownership
- By spouse
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature.
Footnote F2
The reporting person disclaims beneficial ownership of all securities held by her spouse.